Cytosorbents Corp
CTSO
50 hedge funds and large institutions have $11.8M invested in Cytosorbents Corp in 2024 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 18 reducing their positions, and 3 closing their positions.
0% more funds holding
Funds holding: 50 → 50 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
3.01% less ownership
Funds ownership: 33.69% → 30.67% (-3%)
29% less capital invested
Capital invested by funds: $16.7M → $11.8M (-$4.92M)
56% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 18
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$63.8K |
| 2 |
SIG
Sargent Investment Group
Bethesda,
Maryland
|
+$58.3K |
| 3 |
EWA
EP Wealth Advisors
Torrance,
California
|
+$24.3K |
| 4 |
CM
CM Management
Gulf Breeze,
Florida
|
+$21.7K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$11.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$330K |
| 2 |
Neuberger Berman Group
New York
|
-$326K |
| 3 |
AC
Avenir Corporation
Alexandria,
Virginia
|
-$176K |
| 4 |
BlackRock
New York
|
-$57.8K |
| 5 |
SC
Skylands Capital
Milwaukee,
Wisconsin
|
-$30.2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Lazard Asset Management
New York
| – | -$1K | -1,090 | Closed |
|
52
Simplex Trading
Chicago,
Illinois
| – | -$520 | -600 | -97% |
|
53
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | +$346 | +399 | +429% |
|
CTSO Hedge Fund Activity: Q2 2024 in Review
50 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Cytosorbents Corp (CTSO) for Q2 2024, worth a combined $11.8M — down 29% from $16.7M a quarter earlier.
Fund positioning in CTSO was balanced in Q2 2024: 3 funds opened new positions, 3 closed out, 8 added to existing stakes and 18 trimmed.
The largest buyer was Susquehanna International Group, adding an estimated $63.8K. The largest seller was Granahan Investment Management, cutting an estimated $330K.
- 50 institutional investors held Cytosorbents Corp (CTSO) as of Q2 2024, unchanged from Q1 2024.
- Funds reported $11.8M of Cytosorbents Corp stock for Q2 2024, down 29% quarter-over-quarter.
- 3 funds opened new Cytosorbents Corp positions in Q2 2024 and 3 closed out, a net change of 0 holders.
- The largest Cytosorbents Corp buyer in Q2 2024 was Susquehanna International Group, an estimated $63.8K added.
- The largest Cytosorbents Corp seller in Q2 2024 was Granahan Investment Management, an estimated $330K sold.
Based on aggregated 13F filings for Q2 2024.